Ticker LaunchLondon · AIM · IPO · AREC
Arecor Therapeutics Plc
Arecor Therapeutics Plc (AREC) was admitted to AIM on Jun 3, 2021, raising £20M at 226p per share. Its market capitalization at admission was about £62.5M. Panmure Gordon (UK) Limited acted as nominated adviser, with Panmure Gordon (placing agent) as broker.
Arecor Therapeutics is a Cambridge, UK biopharmaceutical company that improves existing therapeutic medicines through reformulation to bring innovative medicines to market, with partnered and proprietary programmes.
- Type
- IPO
- Market
- AIM
- Ticker (TIDM)
- AREC
- Admitted
- Jun 3, 2021
- Offer price
- 226p
- Raised
- £20M
- Market cap at admission
- £62.5M
- Nominated adviser
- Panmure Gordon (UK) Limited
- Brokers
- Panmure Gordon (placing agent)
- Sector
- Biotech & pharma
- Country
- United Kingdom
More on this listing for subscribers
- Intention-to-float date
- New money versus sale shares
- Shares in issue at admission
- ISIN
- Source announcements
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Sources
From company announcements filed with the FCA's National Storage Mechanism. Subscribers see the list of announcements for each listing.
Other London listings around the same time
- Thungela Resources LimitedMain Market · Jun 7, 2021
- The Artisanal Spirits Company PlcAIM · Jun 4, 2021
- Aquila Energy Efficiency Trust PlcMain Market · Jun 2, 2021
- Trellus Health PlcAIM · May 28, 2021
- Belluscura PlcAIM · May 28, 2021
- Taylor Maritime Investments LimitedMain Market · May 27, 2021